miR‐142‐3p restricts cAMP production in CD4<sup>+</sup>CD25<sup>−</sup> T cells and CD4<sup>+</sup>CD25<sup>+</sup> T<sub>REG</sub> cells by targeting AC9 mRNA
Distribution of the number of citations over years.